Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
The Journal of Clinical Psychiatry|April 1, 1988
Risk factors for drug-induced parkinsonism in tardive dyskinesia patientsT E Hansen, W L Brown, R M Weigel, et al.Psychopharmacology|January 1, 1981
Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placeboS Korsgaard, D E Casey, N E Damgaard Pedersen, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1992
Coadministration of haloperidol and SCH-23390 prevents the increase in "perforated" synapses due to either drug aloneC K Meshul, A Janowsky, D E Casey, et al.Psychopharmacology|January 1, 1992
Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortexC K Meshul, A Janowsky, D E Casey, et al.Journal of Geriatric Psychiatry and Neurology|October 1, 1991
Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot studyL Ganzini, R Heintz, W F Hoffman, et al.Neurology|May 1, 1994
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patientsJ G Nutt, W R Woodward, R M Beckner, et al.Orthopedics|March 1, 1996
Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapyM T Carpenter, S G West, S A Vogelgesang, et al.Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.Archives of Neurology|September 18, 1998
Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study GroupK D Sethi, C F O'Brien, J P Hammerstad, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1988
Seven-year follow-up of tardive dyskinesia in Hungarian outpatientsG Gardos, A Perenyi, J O Cole, et al.Pageof 12